top of page
Logo Upscaled JPEG.jpg

The Bridge Between the Adjustment and the Cell


The body is one continuous tissue. This is not metaphor.

The dura mater that wraps the brain and spinal cord is dense connective tissue. It connects, through a structure called the myodural bridge, directly to the suboccipital muscles at the base of the skull. The suboccipital muscles connect through their fascial envelopes to the deep neck musculature. The deep neck musculature connects through continuous fascial planes to the thoracic spine, the shoulder girdle, the diaphragm, the abdominal contents, the pelvic floor, the legs, the feet. From the dura to the soles of the feet, the body is one connective tissue continuity, with no anatomically discrete boundaries between regions.

This is not a recent insight. Practitioners working with the cervical spine have understood the dura-cervical connection in working knowledge for a long time. What has changed in the last two decades is that the specific anatomy of the connection has been mapped with increasing precision, and the biochemistry of how this tissue maintains itself has become more visible.

The myodural bridge consists of dense connective tissue fibers that pass through the posterior atlanto-occipital membrane and attach directly to the spinal dura at the upper cervical levels. The rectus capitis posterior minor and major, the obliquus capitis inferior — these small muscles do not just produce subtle head movement. Through the bridge, they directly transmit mechanical force to the dura that surrounds the brain and spinal cord. Chronic tension in the suboccipital region is, mechanically, chronic tension on the dura.

This explains a great deal about why work at the craniocervical junction affects so much downstream. It is not only the autonomic nervous system pathways, or the vertebral artery dynamics, or the proprioceptive input to the brainstem — though all of these matter. It is also the direct mechanical effect on the dura, and through the dura, on the brain itself and on the cerebrospinal fluid that circulates around it.

The Dura, the Fluid, and What Moves Through Both

Cerebrospinal fluid is produced primarily by the choroid plexus in the brain's ventricles, circulates through the ventricles and the subarachnoid space, and surrounds the brain and spinal cord in continuous flow. The total volume in an adult is roughly 150 milliliters, but production runs at approximately 500 milliliters per day. The entire fluid volume turns over multiple times daily.

Three roles of cerebrospinal fluid matter for the conversation here:

It cushions the brain mechanically, which depends on adequate volume and unrestricted circulation.

It maintains the chemical environment of the central nervous system, including ionic balance, pH regulation, and the diffusion of signaling molecules.

It actively clears metabolic waste from the brain through the glymphatic system, a discovery from approximately 2012 that has reshaped understanding of how the brain maintains itself. Beta-amyloid, tau proteins, and other waste products that accumulate during waking activity are cleared by cerebrospinal fluid flow through the glymphatic pathways, primarily during sleep. Compromised flow correlates with neuroinflammation, cognitive dysfunction, and impaired recovery from neurological stress.

The dura's tension state affects all of this. A dura under chronic tension — from chronic suboccipital tension transmitted through the myodural bridge, from upper cervical misalignment, from sustained sympathetic activation that holds the entire fascial system in a guarded state — affects how cerebrospinal fluid circulates and how the brain sits within its protective envelope. Practitioners who work this region observe these effects directly. The downstream consequences for head pain, cognitive function, sleep quality, and broader nervous system regulation are substantial.

What the Body Has to Maintain

Practitioners working with this tissue observe a pattern. Adjustments produce change. The change is sometimes immediate, sometimes felt over hours. Sometimes the change holds for days or weeks. Sometimes the same patterns return more quickly than either practitioner or patient would expect.

Several explanations are usually offered for the regression. Postural habits return. The patient does not do the prescribed exercises. The underlying emotional patterns that drove the holding have not been addressed. Compensation patterns elsewhere in the body pull the recently-adjusted region back toward its prior position.

All of these explanations are partially true. There is another explanation, less commonly named, that operates underneath all of them.

The body has to maintain the new structural state. Maintenance is biochemical work. The connective tissue that allows the new alignment to hold requires substrate to remain in its current form and to be continuously rebuilt as old tissue breaks down. The nervous system that allows muscle tone to remain at its new setpoint requires neurotransmitters and the cofactors to produce them. The cellular energy that powers all of this requires functioning mitochondria and the substrate they depend on. The inflammatory regulation that keeps the tissue from reverting to its inflamed state requires antioxidant capacity and the methylation pathways that govern it.

When the substrate side of this equation is inadequate, the body cannot maintain what the practitioner has produced. The structural change happens. The biochemical infrastructure to hold it does not arrive. The patterns return, not because the patient failed to follow through on their exercises, but because their tissue does not have what it needs to stabilize in the new configuration.

This is the question worth naming explicitly: not only how does the body change, but what does the body need to hold change once it has been produced?

The Biochemistry of Connective Tissue

Collagen is the primary structural protein of connective tissue — of fascia, of dura, of the muscular envelopes, of skin, of the tendon and ligament structures, of the entire continuous tissue network the body operates as. Approximately one-third of collagen by amino acid composition is glycine. Adequate collagen synthesis is impossible without adequate glycine. Compromised glycine availability produces compromised collagen, which produces compromised connective tissue throughout the body.

Most modern populations do not consume adequate glycine. The food sources richest in it — bone broth, organ meats, connective tissue, skin-on cuts of meat — have largely disappeared from standard diets. The body synthesizes some glycine endogenously, but synthesis requires methylation support and other cofactors that are also inadequate in most modern populations. The substrate for connective tissue maintenance is, quietly, broadly deficient.

Magnesium is required for hundreds of enzymes throughout the body, including those involved in muscle relaxation, nervous system regulation, and cellular energy production. The suboccipital muscles that connect through the myodural bridge to the dura require magnesium for their tone regulation. Chronic magnesium deficiency, widespread in modern populations because of soil depletion, food processing, and dietary patterns, contributes to chronic muscle tension throughout the body, including the cervical region. Releasing tension mechanically without addressing the magnesium substrate produces release that the body cannot sustain.

The methylation cycle — the continuous transfer of methyl groups throughout the body's biochemistry — regulates neurotransmitter synthesis, gene expression, detoxification, and inflammatory cascades. People with variants in MTHFR or COMT (a substantial percentage of the population) have reduced methylation efficiency that affects every system downstream. For the nervous system specifically, compromised methylation produces inadequate neurotransmitter production, reduced capacity to clear stress chemicals, and impaired recovery from sympathetic activation. The patient whose nervous system cannot recover from stress biochemically will hold tension that no amount of mechanical release fully addresses.

The glutathione system, the body's master antioxidant, is required for protecting neural and connective tissues from oxidative damage. The brain produces substantial oxidative stress as a normal byproduct of its activity. Without adequate antioxidant capacity, oxidative damage accumulates in neurons and supporting tissues, contributing to neuroinflammation and reduced capacity for tissue maintenance. The glutathione system depends on cysteine, which the body produces from N-acetylcysteine when supplemented.

The glycocalyx, the carbohydrate-rich protective layer that coats epithelial cells throughout the body, depends on mannose as a structural component. This layer protects the gut lining, the urinary tract, the vascular endothelium, and the blood-brain barrier from inappropriate inflammatory exposure. Compromised glycocalyx contributes to the chronic low-grade inflammation that affects connective tissue health throughout the body, including the dura.

Cellular energy production, the foundation underneath all of this work, depends on creatine availability in the body's metabolically demanding tissues — including the brain, the heart, the gut lining, and the choroid plexus that produces cerebrospinal fluid. Creatine synthesis itself is one of the body's largest consumers of methyl groups. When methylation is compromised, creatine production diminishes, which compromises cellular energy throughout the systems that depend on it.

These pieces are not separate. They are different angles on a single integrated biochemistry that maintains the body the practitioner is working with.

Where Bodywork and Biochemistry Meet

The work happening on the table releases what the body has been holding. The work happening in the cells maintains what the body has released. Neither does the other's job. Both are necessary for sustained change.

Practitioners who recognize this find that their work compounds in ways it did not before. Patients who arrive with depleted substrate and chronic biochemical insufficiency cannot fully use what the practitioner's hands produce. Patients whose substrate is supported, whose methylation is functioning, whose nervous system has the neurotransmitter resources it needs to regulate, hold changes longer, integrate them more fully, and progress through their care plans with momentum that substrate-depleted patients cannot match.

This is not a critique of bodywork. It is a recognition that bodywork operates within a biological system that has substrate requirements, and the substrate requirements of modern populations have become increasingly inadequate to support the work that practitioners are trying to do.

The conversation between practitioners and patients about what to eat, how to sleep, what to supplement, what lifestyle changes to make has always been part of integrated practice. What has shifted is the specificity available now about what the body actually needs at the biochemical level to maintain connective tissue health, nervous system regulation, and the broader systems that bodywork engages with.

Where DBAMTHFR Fits

DBAMTHFR is a six-ingredient methylation support formula built around the foundational biochemistry described in this post. Glycine for connective tissue substrate and nervous system regulation. Magnesium glycinate for muscle relaxation, enzymatic cofactor support, and additional glycine. Trimethylglycine as a direct methyl donor that bypasses MTHFR variants. Creatine for cellular energy production and methyl group conservation. N-acetylcysteine for glutathione production, antioxidant function, and broad detoxification support. D-mannose for glycocalyx integrity and barrier function.

The formula was not designed specifically for the bodywork or chiropractic community. It was designed to address the methylation foundation that underlies many systems, including the connective tissue health, nervous system regulation, and central nervous system support that this post addresses. The connection is incidental in the sense that the formulation predates this specific framing, and direct in the sense that the same biochemistry that the formula supports is the biochemistry that this post is describing.

Practitioners reading this who recognize the substrate question in their own clinical experience may find the formula relevant to the work they are doing — for themselves, for their families, for patients who present with the substrate-depletion patterns that compromise sustained change.

Beyond the connective tissue and nervous system framing of this post, DBAMTHFR addresses broader methylation support that affects energy production, hormone metabolism, detoxification, gut health, mood regulation, sleep quality, and the integration of many other systems that connect to the broader question of how the body maintains itself. The formula is not a connective tissue product. It is a foundational support formula whose mechanisms happen to include the substrates that connective tissue health depends on.

Don't Be An MTHFR
Buy Now

 
 
 

Comments


bottom of page